Harnessing Exci308 to Restore Pigmentation & Revolutionize Autoimmune Skincare
Board-certified dermatologist Cheryl Burgess, MD discusses Aerolase’s new light-based solution, Exci308®.
Internationally acclaimed, board-certified dermatologist Cheryl Burgess joins us to discuss Aerolase’s new light-based solution, Exci308®. This groundbreaking technology has garnered worldwide recognition, proven by more than 200 clinical studies, affirming its position as the most powerful solution for treating autoimmune skin conditions. In this webinar, we will discuss the following topics:
- What is Exci308, and how it differentiates from existing phototherapy devices
- Identifying and understanding the use cases of Exci308
- Addressing Vitiligo and restoring pigmentation to the affected areas
- How the Exci308 compliments existing lasers and devices in any office
Presented by Cheryl Burgess, MD, FAAD
Founder, medical director, and president of the Center for Dermatology and Dermatologic Surgery, PC in Washington, DC. Dr. Burgess is a nationally and internationally recognized expert for advanced technology in non-invasive aesthetic procedures. Currently serving on the Board of Directors for the American Academy of Dermatology.
Harnessing Exci308 to Restore Pigmentation & Revolutionize Autoimmune Skincare
Board-certified dermatologist Cheryl Burgess, MD discusses Aerolase’s new light-based solution, Exci308®.